Latest Stocks: First Analysis Weighs in on Cryolife Inc’s Q2 2017 Earnings (CRY)

Latest Stocks: First Analysis Weighs in on Cryolife Inc’s Q2 2017 Earnings (CRY)

CRY has been the subject of several other reports. Zacks Investment Research lowered Cryolife from a “hold” rating to a “sell” rating in a report on Thursday, February 23rd. Northland Securities reaffirmed a “buy” rating and set a $23.50 target price on shares of Cryolife in a report on Friday, April 28th. Finally, Ladenburg Thalmann Financial Services raised Cryolife from a “neutral” rating to a “buy” rating and set a $20.00 target price for the company in a report on Friday, February 17th. One analyst has rated the stock with a sell rating and five have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $19.67. Shares of Cryolife (NYSE CRY) opened at 18.20 on Tuesday. The firm’s 50-day moving average price is $17.84 and its 200-day moving average price is $17.91. The firm has a market capitalization of $605.33 million, a PE ratio of 59.09 and a beta of 1.23. Cryolife has a 52-week low of $11.35 and a 52-week high of $20.15.

Cryolife Inc (NYSE:CRY) – Equities researchers at First Analysis decreased their Q2 2017 earnings estimates for Cryolife in a research report issued to clients and investors on Monday. First Analysis analyst now forecasts that the medical equipment provider will earn $0.07 per share for the quarter, down from their previous forecast of $0.11. First Analysis also issued estimates for Cryolife’s Q3 2017 earnings at $0.08 EPS, Q4 2017 earnings at $0.10 EPS, FY2017 earnings at $0.31 EPS and FY2018 earnings at $0.39 EPS.

Cryolife (NYSE:CRY) last posted its quarterly earnings data on Wednesday, April 26th. The medical equipment provider reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.05. Cryolife had a return on equity of 8.37% and a net margin of 6.00%. The company had revenue of $45.10 million during the quarter, compared to analysts’ expectations of $44.64 million. During the same period last year, the firm earned $0.10 EPS. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. Institutional investors have recently bought and sold shares of the stock. Municipal Employees Retirement System of Michigan raised its position in Cryolife by 3.2% in the first quarter. Municipal Employees Retirement System of Michigan now owns 6,150 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 190 shares during the period. Mason Street Advisors LLC raised its position in Cryolife by 7.4% in the first quarter. Mason Street Advisors LLC now owns 6,324 shares of the medical equipment provider’s stock valued at $105,000 after buying an additional 438 shares during the period. Karp Capital Management Corp bought a new position in Cryolife during the first quarter valued at approximately $172,000. Louisiana State Employees Retirement System raised its position in shares of Cryolife by 1.9% in the first quarter. Louisiana State Employees Retirement System now owns 11,000 shares of the medical equipment provider’s stock worth $183,000 after buying an additional 200 shares during the period. Finally, Arizona State Retirement System raised its position in shares of Cryolife by 1.4% in the first quarter. Arizona State Retirement System now owns 14,054 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 200 shares during the period. 66.30% of the stock is owned by institutional investors.

Receive News & Ratings for Cryolife Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cryolife Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment